ED
EXPO icon

Exane Derivatives’s Exponent EXPO Stock Holding History

Exane Derivatives’s Portfolio EXPO Stock Details EXPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$206K Sell
2,257
-1
-0% -$94 0.12% 161
2022
Q1 		$244K Sell
2,258
-21
-0.9% -$2.02K 0.07% 283
2021
Q4 		$266K Buy
2,279
+184
+9% +$21.6K 0.06% 285
2021
Q3 		$237K Sell
2,095
-110
-5% -$11.9K 0.06% 352
2021
Q2 		$199K Buy
+2,205
New +$206K 0.05% 391

Other funds holding EXPO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Exane Derivatives's EXPO Position: Q2 2022 in Review

Exane Derivatives reduced its Exponent (EXPO) stake by 0.04% in Q2 2022, selling an estimated $94 and leaving 2,257 shares worth $206K. The position accounts for 0.12% of the portfolio, ranked #161.

Exane Derivatives first reported a position in EXPO in Q2 2021 and has held it in 5 quarters since. The position peaked at $266K in Q4 2021. 348 funds tracked by Wall St. Rank hold EXPO as of Q2 2022.

  • Exane Derivatives held 2,257 shares of Exponent worth $206K as of Q2 2022.
  • Exane Derivatives sold 1 Exponent share in Q2 2022, an estimated $94.
  • Exponent made up 0.12% of Exane Derivatives's portfolio in Q2 2022, its #161 holding.
  • Exane Derivatives first reported a position in Exponent in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's Exponent position peaked at $266K in Q4 2021.
  • 348 funds tracked by Wall St. Rank held Exponent as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.